Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gøransson, L. G.
Right arrow Articles by Bergrem, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gøransson, L. G.
Right arrow Articles by Bergrem, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 318-319
© 2002 European Renal Association-European Dialysis and Transplant Association

Letters

Disappearance of measurable mycophenolate mofetil (Cell Cept®) in a patient with a renal transplant and an ileostomy

Lasse Gunnar Gøransson and Harald Bergrem

Department of Medicine, Renal Unit, Central Hospital of Rogaland, Stavanger, Norway

Sir,

Mycophenolate mofetil is a potent, uncompetitive, reversible inhibitor of eukaryotic inosine monophosphate dehydrogenase. It is effective in the suppression of acute allograft rejection following cadaveric renal transplantation when given orally twice daily in combination with cyclosporin and steroids [1]. Its clinical pharmacology, including its intestinal absorption characteristics, has been . . . [Full Text of this Article]

Case.

Discussion.

Conclusion.

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?